INCREASING PROSTATE CANCER DETECTION BY A MODEL INCLUDING PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3)

被引：0
|
作者：
Ferro, Matteo [1 ]
Marino, Ada [2 ]
Gargiulo, Liberato [2 ]
Cosimato, Vincenzo [2 ]
Mazzarella, Claudia [2 ]
Perruolo, Giuseppe [2 ]
Bruzzese, Dario [3 ]
Terracciano, Daniela [2 ]
Cimmino, Amelia [4 ]
Scafuro, Chiara [5 ]
Mastella, Federica [5 ]
Montanaro, Vittorino [5 ]
Altieri, Vincenzo [6 ]
Perdona, Sisto [7 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[3] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[4] CNR, Inst Genet & Biophys, I-80125 Naples, Italy
[5] AO San Giovanni di Dio & Ruggi D Aragona, Dept Urol, Salerno, Italy
[6] Univ Salerno, Dept Urol, Salerno, Italy
[7] Fdn G Pascale, Ist Nazl Tumori, Urol Sect, Dept Urol, Naples, Italy
来源：
ANTICANCER RESEARCH | 2013年 / 33卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44
引用
收藏
页码：2275 / 2276
页数：2
相关论文
共 50 条
  • [41] PCA3 TEST AS AN ADJUNCT IN DIAGNOSIS OF PROSTATE CANCER
    Yutkin, Vladimir
    Al-Zahrani, Ali
    Williams, Andrew
    Hidas, Guy
    Martinez, Carlos
    Izawa, Jonathan
    Pode, Dov
    Chin, Joseph
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E889 - E889
  • [42] PCA3: A molecular urine prostate cancer test
    Rittenhouse, Harry
    [J]. TUMOR BIOLOGY, 2007, 28 : 50 - 50
  • [43] Specificity of the APTIMA® PCA3 assay for prostate cancer
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 240 - 240
  • [44] Specificity of the APTIMA® PCA3 assay for prostate cancer
    Marks, LS
    Aubin, SMJ
    Deras, IL
    Brentano, S
    Blase, A
    Bodrug, S
    Macairan, ML
    Ko, TY
    Rittenhouse, HG
    Groskopf, J
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 175 - 176
  • [45] HEAD-TO-HEAD COMPARISON OF PROSTATE HEALTH INDEX AND URINARY PCA3 ASSAY IN PREDICTING PROSTATE CANCER AT INITIAL OR REPEAT PROSTATE BIOPSY
    Scattoni, Vincenzo
    Lazzeri, Massimo
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Randone, Donato
    Abdollah, Firas
    Capitanio, Umberto
    Maccagnano, Carmen
    Lughezzani, Giorgio
    Lista, Giuliana
    Gadda, Giulio Maria
    Larcher, Alessandro
    Montorsi, Francesco
    Guazzoni, Giorgio
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E912 - E912
  • [46] Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
    Kirby, Roger S.
    Fitzpatrick, John M.
    Irani, Jacques
    [J]. BJU INTERNATIONAL, 2009, 103 (04) : 441 - 445
  • [47] Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
    Roobol, Monique J.
    Schroder, Fritz H.
    van Leeuwen, Pim
    Wolters, Tineke
    van den Bergh, Roderick C. N.
    van Leenders, Geert J. L. H.
    Hessels, Daphne
    [J]. EUROPEAN UROLOGY, 2010, 58 (04) : 475 - 481
  • [48] Predicting prostate biopsy results—PCA3 versus phi
    Stacy Loeb
    [J]. Nature Reviews Urology, 2015, 12 : 130 - 131
  • [49] Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
    Goode, Roland R.
    Marshall, Susan J.
    Duff, Michael
    Chevli, Eric
    Chevli, K. Kent
    [J]. PROSTATE, 2013, 73 (01): : 48 - 53
  • [50] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Rubio-Briones, Jose
    Borque, Angel
    Esteban, Luis M.
    Casanova, Juan
    Fernandez-Serra, Antonio
    Rubio, Luis
    Casanova-Salas, Irene
    Sanz, Gerardo
    Dominguez-Escrig, Jose
    Collado, Argimiro
    Gomez-Ferrer, Alvaro
    Iborra, Inmaculada
    Ramirez-Backhaus, Miguel
    Martinez, Francisco
    Calatrava, Ana
    Lopez-Guerrero, Jose A.
    [J]. BMC CANCER, 2015, 15
12345